The epigenetic reader BRWD1 in peripheral adaptive immunity
The epigenetic reader BRWD1 in peripheral adaptive immunity
批准号:
10541126
负责人:
Marcus Ramsay Clark
金额:
$48.78万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-01-10 至 2024-12-31
关键词:
3-DimensionalATAC-seqAffectAffinityAllelesAntibodiesAntigensApplications GrantsAttenuatedAutoimmunityB-Cell DevelopmentB-LymphocytesBindingBinding SitesBone MarrowCellsChIP-seqCharacteristicsChimera organismChromatinChromatin StructureDNADarknessDataDefectDevelopmentEnhancersEphrin-A5Epigenetic ProcessFailureFlow CytometryFollicular Dendritic CellsGene Expression ProfileGene Expression RegulationGenesGenetic TranscriptionGenomeHeterogeneityHi-CHistologicHumanHumoral ImmunitiesIRF4 geneIgKImmunizationImmunizeImmunoglobulin Class SwitchingIn SituInfectionKnowledgeLightLymphopoiesisMalignant NeoplasmsMolecularMusMutationNucleosomesPatientsPatternPeripheralPhenotypePopulationPositioning AttributeReaderRegulationReportingRepressionRoleShapesSortingStructureStructure of germinal center of lymph nodeT-LymphocyteTestingTranscriptional RegulationWD RepeatWorkadaptive immunitydesigndifferential expressionfightinggenome-widehypogammaglobulinemialymph nodesmolecular modelingnovelnovel therapeuticsprogramsquantitative imagingrecruitresponsesingle-cell RNA sequencingthree dimensional structuretranscription factorvaccine efficacy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Recently, we demonstrated that the lineage-restricted BROMO and WD40 domain containing epigenetic reader
BRWD1 opens Igk and induces an epigenetic landscape that enables assembly of RAG proteins at Jk. We now
report that BRWD1 has a much broader role in late B cell development. BRWD1 reshapes chromatin landscapes
by closing enhancers of genes expressed early in B cell development and opening those of genes expressed in
late stages. BRWD1 did not affect the expression of critical transcription factors (TFs). Rather, as demonstrated
for IRF4, BRWD1 determines the sites they bind across the genome. BRWD1 differentially regulated over 7000
genes, repressing proliferative and inducing differentiation programs. Notably, BRWD1 coordinately repressed
Myc and Myc target genes. Furthermore, in humans, BRWD1 mutations are associated with
hypogammaglobulinemia. These data indicate that, in both mice and humans, BRWD1 is a master orchestrator
of enhancer accessibility that cooperates with TF networks to drive late B cell development.
BRWD1 is first expressed in small pre-B cells. However, Brwd1 expression is higher in naïve follicular (FO)
and in germinal center (GC) dark zone (DZ) cells. Analysis of genes differentially expressed in GC DZ and light
zone (LZ) cells, compared to those differentially regulated by BRWD1 in small pre-B cells, predicts that BRWD1
represses the DZ program and induces the LZ program. Furthermore, differential genome-wide binding of
BRWD1 in DZ and LZ cells suggests different functions in each GC subset. Immunizing Brwd1fl/fl x Aicda (AID)-
Cre mice revealed that BRWD1 was required for normal antibody isotype switching and affinity maturation.
Histologically, GCs were greatly reduced in both size, and number, and lacked follicular dendritic cells. Therefore,
we hypothesize that BRWD1 regulates epigenetic states and enhancer landscapes critical for coordination of DZ
and LZ transcriptional programs and GC function. We will test this hypothesis in the following Specific Aims:
Aim 1. Determine the transcriptional regulation of normal germinal center responses.
Aim 2. Determine the role of BRWD1 in adaptive immunity.
Aim 3. Determine the role of BRWD1 in initiating GC responses and in maintaining FO B cell identity. !
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI:
10.3389/fimmu.2021.659151
发表时间:
2021
期刊:
Frontiers in immunology
影响因子:
7.3
作者:
[Kennedy DE, Clark MR]
通讯作者:
Clark MR
DOI:
10.1016/j.it.2023.06.010
发表时间:
2023-08
期刊:
Trends in immunology
影响因子:
16.8
作者:
[Nathaniel E. Wright;M. Mandal;M. Clark]
通讯作者:
Nathaniel E. Wright;M. Mandal;M. Clark
Comprehensive characterization of immune signaling networks in single-cells by joint quantification of proteins, protein complexes and mRNA
-
批准号:10636695
-
项目类别:
-
资助金额:$67.31万
-
财政年份:2023
-
负责人:Marcus Ramsay Clark
-
依托单位:
Medical Scientist National Research Service Award
-
批准号:10869820
-
项目类别:
-
资助金额:$17.42万
-
财政年份:2023
-
负责人:Marcus Ramsay Clark
-
依托单位:
Medical Scientist National Research Service Award
-
批准号:10703834
-
项目类别:
-
资助金额:$127.72万
-
财政年份:2023
-
负责人:Marcus Ramsay Clark
-
依托单位:
Role of CXCR4 in immunoglobulin light chain recombination
-
批准号:10569055
-
项目类别:
-
资助金额:$57.96万
-
财政年份:2021
-
负责人:Marcus Ramsay Clark
-
依托单位:
Role of CXCR4 in immunoglobulin light chain recombination
-
批准号:10117864
-
项目类别:
-
资助金额:$57.96万
-
财政年份:2021
-
负责人:Marcus Ramsay Clark
-
依托单位:
Role of CXCR4 in immunoglobulin light chain recombination
-
批准号:10368138
-
项目类别:
-
资助金额:$57.96万
-
财政年份:2021
-
负责人:Marcus Ramsay Clark
-
依托单位:
The epigenetic reader BRWD1 in peripheral adaptive immunity
-
批准号:10077826
-
项目类别:
-
资助金额:$48.78万
-
财政年份:2019
-
负责人:Marcus Ramsay Clark
-
依托单位:
The epigenetic reader BRWD1 in peripheral adaptive immunity
-
批准号:10321252
-
项目类别:
-
资助金额:$48.78万
-
财政年份:2019
-
负责人:Marcus Ramsay Clark
-
依托单位:
BRWD1 in adaptive humoral immunity
-
批准号:9307294
-
项目类别:
-
资助金额:$24.19万
-
财政年份:2017
-
负责人:Marcus Ramsay Clark
-
依托单位:
BRWD1 in adaptive humoral immunity
-
批准号:9413989
-
项目类别:
-
资助金额:$20.25万
-
财政年份:2017
-
负责人:Marcus Ramsay Clark
-
依托单位:
Regulation of Ig-kappa recombination during B lymphopoiesis
-
批准号:9257272
-
项目类别:
-
资助金额:$46.19万
-
财政年份:2015
-
负责人:Marcus Ramsay Clark
-
依托单位:
Regulation of Ig-kappa recombination during B lymphopoiesis
-
批准号:9474100
-
项目类别:
-
资助金额:$46.19万
-
财政年份:2015
-
负责人:Marcus Ramsay Clark
-
依托单位:
In situ tolerance in autoimmunity
-
批准号:8732778
-
项目类别:
-
资助金额:$7.9万
-
财政年份:2014
-
负责人:Marcus Ramsay Clark
-
依托单位:
In vivo functions of Ig-beta ubiquitinylation
-
批准号:8976272
-
项目类别:
-
资助金额:$29.6万
-
财政年份:2012
-
负责人:Marcus Ramsay Clark
-
依托单位:
In vivo functions of Ig-beta ubiquitinylation
-
批准号:8595320
-
项目类别:
-
资助金额:$29.6万
-
财政年份:2012
-
负责人:Marcus Ramsay Clark
-
依托单位:
In vivo functions of Ig-beta ubiquitinylation
-
批准号:8436646
-
项目类别:
-
资助金额:$29.6万
-
财政年份:2012
-
负责人:Marcus Ramsay Clark
-
依托单位:
In vivo functions of Ig-beta ubiquitinylation
-
批准号:8824783
-
项目类别:
-
资助金额:$2.96万
-
财政年份:2012
-
负责人:Marcus Ramsay Clark
-
依托单位:
Regulation of cyclin D3 in B lymphocyte development
-
批准号:7983829
-
项目类别:
-
资助金额:$31.65万
-
财政年份:2010
-
负责人:Marcus Ramsay Clark
-
依托单位:
Regulation of cyclin D3 in B lymphocyte development
-
批准号:8134331
-
项目类别:
-
资助金额:$29.94万
-
财政年份:2010
-
负责人:Marcus Ramsay Clark
-
依托单位:
Regulation of cyclin D3 in B lymphocyte development
-
批准号:8516370
-
项目类别:
-
资助金额:$28.89万
-
财政年份:2010
-
负责人:Marcus Ramsay Clark
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于ATAC-seq与DNA甲基化测序探究染色质可及性对莲两生态型地下茎适应性分化的作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
利用ATAC-seq联合RNA-seq分析TOP2A介导的HCC肿瘤细胞迁移侵
袭的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:柳静
-
依托单位:
面向图神经网络ATAC-seq模体识别的最小间隔单细胞聚类研究
-
批准号:62302218
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:张双全
-
依托单位:
基于ATAC-seq策略挖掘穿心莲基因组中调控穿心莲内酯合成的增强子
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:黄铭坤
-
依托单位:
基于单细胞ATAC-seq技术的C4光合调控分子机制研究
-
批准号:32100438
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:涂晓雨
-
依托单位:
基于ATAC-seq技术研究交叉反应物质197调控TFEB介导的自噬抑制子宫内膜异位症侵袭的分子机制
-
批准号:82001520
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:汤小晗
-
依托单位:
靶向治疗动态调控肺癌细胞DNA可接近性的ATAC-seq分析
-
批准号:81802809
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:蔡梅春
-
依托单位:
运用ATAC-seq技术分析染色质可接近性对犏牛初级精母细胞基因表达的调控作用
-
批准号:31802046
-
项目类别:青年科学基金项目
-
资助金额:27.0万元
-
批准年份:2018
-
负责人:张龚炜
-
依托单位:
基于ATAC-seq和RNA-seq研究CWIN调控采后番茄果实耐冷性作用机制
-
批准号:31801915
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2018
-
负责人:茹磊
-
依托单位:
基于ATAC-seq高精度预测染色质相互作用的新方法和基于增强现实的3D基因组数据可视化
-
批准号:31871331
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2018
-
负责人:张治华
-
依托单位: